These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3271333)

  • 1. Ancrod in glomerulonephritis.
    Becker GJ
    Q J Med; 1988 Nov; 69(259):849-50. PubMed ID: 3271333
    [No Abstract]   [Full Text] [Related]  

  • 2. Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.
    Pollak VE; Glueck HI; Weiss MA; Lebron-Berges A; Miller MA
    Am J Nephrol; 1982; 2(4):195-207. PubMed ID: 6816068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.
    Kant KS; Pollak VE; Dosekun A; Glas-Greenwalt P; Weiss MA; Glueck HI
    J Lab Clin Med; 1985 Jan; 105(1):77-88. PubMed ID: 3968467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly progressive glomerulonephritis: treatment with combined immunosuppression and anticoagulation with arvin.
    Segasothy M; Kong CT; Morad Z; Suleiman AB; Phang KS
    Singapore Med J; 1986 Oct; 27(5):422-7. PubMed ID: 3823948
    [No Abstract]   [Full Text] [Related]  

  • 5. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant therapy with ancrod.
    Soutar RL; Ginsberg JS
    Crit Rev Oncol Hematol; 1993 Aug; 15(1):23-33. PubMed ID: 8240705
    [No Abstract]   [Full Text] [Related]  

  • 7. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
    Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
    J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ancrod.
    Sherman DG
    Curr Med Res Opin; 2002; 18 Suppl 2():s48-52. PubMed ID: 12365829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of ancrod in acute ischemic stroke. Independent Data and Safety Monitoring Board for ESTAT. Steering Committee for ESTAT. European Stroke Treatment with Ancrod Trial.
    Orgogozo JM; Verstraete M; Kay R; Hennerici M; Lenzi GL
    JAMA; 2000 Oct; 284(15):1926-7. PubMed ID: 11035887
    [No Abstract]   [Full Text] [Related]  

  • 10. Ancrod (Arvin).
    Drug Ther Bull; 1977 Oct; 15(22):87-8. PubMed ID: 590089
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin-induced thrombosis treated with ancrod.
    Brennan MB; MacKean GL
    Can J Surg; 1994 Apr; 37(2):161-4. PubMed ID: 8156472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of ancrod in acute ischemic stroke.
    Orbach D; Levine D
    JAMA; 2000 Oct; 284(15):1926; author reply 1927. PubMed ID: 11035886
    [No Abstract]   [Full Text] [Related]  

  • 13. Ancrod as prophylaxis or treatment for thromboembolism in patients with multiple trauma.
    Cole CW; Shea B; Bormanis J
    Can J Surg; 1995 Jun; 38(3):249-54. PubMed ID: 7788603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple courses of ancrod (Arvin) therapy.
    Kounis NG; Evans WH
    Br Med J; 1977 Jan; 1(6056):290-1. PubMed ID: 837082
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging studies on the effect of the fibrinogen-lowering agent ancrod on cerebral lesions in two rat models of acute stroke.
    Elger B; Laux V; Schwarz M
    Arzneimittelforschung; 1997 Aug; 47(8):895-9. PubMed ID: 9296273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired resistance to prolonged treatment with intravenous "Arvin" (ancrod).
    Thomson NC; Hutcheon AW; Dagg JH
    Br J Clin Pract; 1976; 30(11-12):232-3. PubMed ID: 1008987
    [No Abstract]   [Full Text] [Related]  

  • 18. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 19. Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects.
    Dosekun AK; Pollak VE; Glas-Greenwalt P; Kant KS; Penovich P; Lebron-Berges A; Weiss MA; Levinson JE
    Arch Intern Med; 1984 Jan; 144(1):37-42. PubMed ID: 6229228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple courses of ancrod (Arvin) therapy.
    Br Med J; 1977 Feb; 1(6059):508-9. PubMed ID: 837184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.